Marc Le Bert Selected Research

Marc Le Bert Research Topics

Disease

13	Inflammation (Inflammations) 01/2023 - 01/2008
13	Pneumonia (Pneumonitis) 01/2023 - 01/2008
6	Infections 01/2019 - 04/2007
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2008
4	Fibrosis (Cirrhosis) 10/2019 - 01/2011
4	Tuberculosis (Tuberculoses) 11/2016 - 04/2007
3	Bites and Stings (Sting) 01/2020 - 12/2018
3	Emphysema 10/2019 - 01/2008
2	Anemia 01/2022 - 11/2021
2	Lung Injury 01/2020 - 01/2011
2	Ileitis 01/2020 - 01/2019
2	Hyperplasia 11/2019 - 01/2012
2	Asthma (Bronchial Asthma) 01/2018 - 02/2012
1	Dyspnea (Shortness of Breath) 01/2023
1	Iron Overload 01/2022
1	Autistic Disorder (Autism) 11/2021
1	Hydronephrosis 11/2021
1	Type II Xanthinuria 11/2021
1	Necrosis 11/2021
1	Urolithiasis 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Arthritis (Polyarthritis) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Metaplasia 11/2019
1	Cysts 01/2019
1	Edema (Dropsy) 01/2018
1	Temporal Lobe Epilepsy 01/2018
1	Gout 01/2018
1	Malaria 01/2018
1	Respiratory Hypersensitivity 05/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Eosinophilia 11/2016
1	Weight Loss (Weight Reduction) 01/2014
1	Rheumatoid Arthritis 04/2007

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2022 - 04/2007
5	SmokeIBA 01/2023 - 01/2008
4	InflammasomesIBA 01/2023 - 01/2011
4	Interleukin-22 (IL-22)IBA 01/2021 - 02/2012
4	CollagenIBA 01/2020 - 01/2011
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2018
3	InterferonsIBA 01/2020 - 12/2018
3	AllergensIBA 01/2018 - 11/2016
3	Interleukin-1 (Interleukin 1)IBA 10/2013 - 01/2008
2	ChemokinesIBA 01/2022 - 01/2020
2	Interleukin-33IBA 01/2019 - 01/2018
2	Neutralizing AntibodiesIBA 01/2019 - 11/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 01/2011
2	PapainIBA 01/2018 - 11/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 11/2016
2	Interleukin-23 Subunit p19IBA 10/2013 - 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	metal transporting protein 1 (ferroportin)IBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	NucleotidesIBA 01/2022
1	IronIBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	CaspasesIBA 01/2022
1	PurinesIBA 11/2021
1	purineIBA 11/2021
1	UromodulinIBA 11/2021
1	Amino Acids FDA Link 11/2021
1	molybdopterin (molybdenum cofactor)IBA 11/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2021
1	XanthineIBA 11/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Interferon LambdaIBA 01/2020
1	B-Cell Activating FactorIBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	ElastinIBA 11/2019
1	Interferon Type IIBA 10/2019
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 12/2018
1	Deoxyribonuclease I (Nickase)IBA 12/2018
1	Mefloquine (Lariam)FDA LinkGeneric 01/2018
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Kainic Acid (Kainate)IBA 01/2018
1	Probenecid (Benemid)FDA LinkGeneric 01/2018
1	compound 20IBA 05/2017
1	Transcription Factors (Transcription Factor)IBA 05/2017
1	AntibodiesIBA 11/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2016
1	Fumigant 93 (D-D)IBA 01/2014
1	EndotoxinsIBA 01/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2013
1	Interleukin-23 (Interleukin 23)IBA 01/2011
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2008
1	Toll-Like Receptor 4IBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007

Therapy/Procedure

3	Therapeutics 12/2018 - 04/2007
1	Airway Management 01/2023
1	Oral Administration 01/2018
1	Intranasal Administration 01/2012